BLTE
Belite Bio Inc ADR
NASDAQ: BLTE · HEALTHCARE · BIOTECHNOLOGY
$154.50
-2.66% today
Updated 2026-04-29
Market cap
$6.17B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.32
Dividend yield
—
52W range
$56 – $200
Volume
0.2M
Belite Bio Inc ADR (BLTE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-4.44M | $-7.47M | $-11.46M | $-29.84M | $-29.23M | $-36.99M |
| Capital expenditures | $20000.00 | $74000.00 | $394000.00 | $63000.00 | $151000.00 | $178000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $1.36M | $1.53M | $1.48M | $3.82M | $8.99M | $38.92M |
| Free cash flow | $-4.46M | $-7.55M | $-11.85M | $-29.90M | $-29.39M | $-37.17M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |